Compass Therapeutics (CMPX) Assets Average (2023 - 2025)
Historic Assets Average for Compass Therapeutics (CMPX) over the last 3 years, with Q3 2025 value amounting to $174.0 million.
- Compass Therapeutics' Assets Average rose 1417.34% to $174.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $174.0 million, marking a year-over-year increase of 1417.34%. This contributed to the annual value of $148.6 million for FY2024, which is N/A changed from last year.
- According to the latest figures from Q3 2025, Compass Therapeutics' Assets Average is $174.0 million, which was up 1417.34% from $124.1 million recorded in Q2 2025.
- Compass Therapeutics' 5-year Assets Average high stood at $183.6 million for Q2 2023, and its period low was $124.1 million during Q2 2025.
- Over the past 3 years, Compass Therapeutics' median Assets Average value was $158.7 million (recorded in 2024), while the average stood at $157.0 million.
- Data for Compass Therapeutics' Assets Average shows a peak YoY increase of 1417.34% (in 2025) and a maximum YoY decrease of 2165.85% (in 2025) over the last 5 years.
- Quarter analysis of 3 years shows Compass Therapeutics' Assets Average stood at $163.5 million in 2023, then decreased by 11.43% to $144.8 million in 2024, then rose by 20.17% to $174.0 million in 2025.
- Its last three reported values are $174.0 million in Q3 2025, $124.1 million for Q2 2025, and $135.9 million during Q1 2025.